-
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe | Morningstar
来源: Buzz FX / 13 11月 2024 20:50:29 America/New_York
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and
Read more...